Two possible cases of erenumab-induced xerostomia.

Pablo Selvi-Sabater Miguel Angel Carvajal-Sanchez Francisco Javier Carrera-Hueso

Published in: Journal of clinical pharmacy and therapeutics (2021)

Xerostomia is not described as an adverse reaction in the drug's technical datasheet. A search was made in PubMed including 'erenumab', 'fremanezumab', 'galcanezumab', 'xerostomia', and no results were found. It is necessary to identify this potential adverse reaction in order to estimate its prevalence and possible impact on patients' quality of life.

Keyphrases

end stage renal disease
ejection fraction
newly diagnosed
chronic kidney disease
adverse drug
prognostic factors
risk factors
emergency department
drug induced
high glucose
climate change
endothelial cells
patient reported